Search

everythinglearnresearchcommunity

for

Search:↓

Some people experience severe, long-lasting side effects from fluoroquinolone antibiotics, leading to the recommendation of limited use and increased awareness of these risks.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

New method effectively analyzes finasteride and its stability.

Get head MRI for babies with achondroplasia early, use free immunoglobulin light chains to detect certain neurodevelopmental disorders, and video calls work for speech therapy in patients with facial anomalies.

The new skin cream with FOL-005 safely promotes hair growth and is stable and user-friendly.

The UK High Court revoked Lundbeck's patent for Escitalopram, and second medical use claims based on dosage were not considered novel.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

Light and temperature affect the daily skin function rhythms in hairless rats, with temperature influencing water loss but not skin hydration.

Enhancing melanin's energy generation may help treat alopecia areata.

UK medical students lack dermatology education, liver biopsy patients with risk factors show more fibrosis, and certain fungi resist drugs due to melanin; genetics may influence female hair loss.

Three drugs change mice's alcohol drinking patterns by affecting GABAA receptors.

New technologies in acupuncture and biosensors show promise for better medical treatments and healing.

Minoxidil not effective in preventing chemotherapy-induced hair loss.

Stem cells are key for the growth, upkeep, and repair of sebaceous glands and for understanding skin disorders.

Both a lock of hair and a single hair strand can show chronic drug use, but at least six single hairs are needed for accurate results.

New materials help control stem cell growth and specialization for medical applications.

Entrepreneurial companies are key to advancing dermatology treatments and patient care.

Hair follicle testing is more reliable and effective for drug screening than urinalysis.

A new method can quickly and accurately detect drugs in hair.

Patch testing with different solvents helps find the right minoxidil formulation for those with scalp allergies.

Antiyeast treatments work better for seborrheic dermatitis than steroids, and other findings include increased skin bacteria under plastic wrap, a nasal cell defect in Staphylococcus aureus carriers, quick resolution of certain skin reactions, high rubber latex allergy in spina bifida patients, and glyceryl monopentadecanoate's effectiveness for male hair loss.

Hair protein analysis could improve medical testing and understanding of hair characteristics.

The C3H/HeJ mouse model is useful for studying and testing treatments for alopecia areata.

Thermoresponsive nanogels show promise for delivering medicine through the skin but need more safety testing and regulatory approval before clinical use.

Myotonic dystrophy should be considered in patients with hair thinning, and genetic counseling is important.

Minoxidil gels with higher concentrations are more stable and effective for treating hair loss.

Human hair follicle organ culture is a useful model for hair research with potential for studying hair biology and testing treatments.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

Drug repurposing speeds up drug development, saves money, and has led to about a third of new drug approvals.